Animal study · rats

IGF-1 LR3: several times as potent as IGF-I for gut growth in rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

In rats, IGF-1 LR3 drove gut growth the same way standard IGF-I did but at several times the potency, and the gut ranked among the tissues that respond most strongly to IGF-I.

Kind
Animal study
Studied in
Rats
Published
1992
Journal
J Endocrinol

What they tested

The team compared how IGF-I and two altered forms that bind less to IGF-binding proteins, including IGF-1 LR3, affect the gut in rats.

How the study was done

A comparative study in 150 g rats given dexamethasone, which put them in a catabolic (tissue-breakdown) state. Over 7 days they received IGF-I, des(1-3)IGF-I or IGF-1 LR3 at a range of doses.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking IGF-1 LR3? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, IGF-I raised total gut weight more as the dose rose. The top dose of 695 micrograms/day raised gut weight by up to 60% and gut weight relative to body weight by up to 32%, with effects in the stomach, small intestine and colon. The gut grew thicker rather than longer, with gains in both the inner lining (mucosa) and the muscle layer, while protein synthesis in the duodenum on day 7 did not rise. IGF-1 LR3 and the other altered form worked the same way as IGF-I, and in every comparison they were several times as potent.

What it doesn’t show

This was a short, 7-day study in rats made catabolic with dexamethasone, so it is not a human result. It looked at gut size and makeup, not at gut function or health outcomes.

The paper

Read et al. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol. 1992.

The compound

More studies on IGF-1 LR3

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking IGF-1 LR3? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo